Canara HSBC Life Insurance Company Limited announced that its shareholders have approved the reappointment of two Non-Executive Independent Directors for a second term of three consecutive years. The approvals were secured through a postal ballot conducted via remote e-voting, concluding on October 16, 2026.

The resolutions sought approval for the reappointment of Dr. Kishore Kumar Sansi and Mr. Supratim Bandyopadhyay. Both items were passed as Special Resolutions, requiring a majority of not less than three-fourths of the total votes cast in favour of the resolution.

Voting results for Dr Kishore Kumar Sansi

The reappointment of Dr. Kishore Kumar Sansi received overwhelming support from the promoter group, who voted 100% in favour. Institutional investors also largely supported the resolution, with 95.53% of votes cast by institutions in favour. However, non-institutional public shareholders showed a higher dissent rate, with 9.67% voting against the resolution.

Voting results for Mr Supratim Bandyopadhyay

Mr. Supratim Bandyopadhyay’s reappointment witnessed even stronger institutional support, with 99.93% of institutional votes cast in his favour. Similar to the previous resolution, non-institutional public shareholders recorded a dissent rate of approximately 9.66%.

What the numbers show

A distinct divergence exists between institutional and retail shareholder sentiment regarding these reappointments. While institutional investors voted overwhelmingly in favour of Mr. Bandyopadhyay (99.93%), they showed notable resistance to Dr. Sansi’s reappointment, with 4.47% of institutional votes cast against him. This contrasts sharply with the near-unanimous support from the promoter group for both directors. The data suggests that institutional scrutiny was more pronounced regarding Dr. Sansi’s continued tenure compared to Mr. Bandyopadhyay’s.

Canara HSBC Life Insurance Company Limited reported H1FY27 net profit of ₹712 million, up 11% from ₹642 million in the corresponding period last year. Value of New Business (VNB) rose 24% to ₹2,658 million, with margins expanding to 21.3%. The company also released the audio recording of its analyst meet discussing these results on October 9, 2026.

The insurer’s Board approved the issuance of Non-Convertible Debentures (NCDs) worth up to ₹28.75 billion in one or more tranches on a private placement basis. This capital infusion aims to support growth trajectories and regulatory requirements without diluting equity holdings.

Financial performance highlights

The company’s top-line growth reflects steady expansion in business volumes, driven by a rise in both first-year and renewal premiums. However, income from investments turned negative due to Mark-to-Market impacts on equity-linked funds.

What the Numbers Show

While net premium income grew robustly by 13%, the company reported a deficit of ₹11.49 million in its Policyholders' Account for Q2FY27, compared to a surplus of ₹112.32 million in Q2FY26. This swing was primarily driven by negative investment income of ₹3.34 billion (net), attributed to Mark-to-Market losses in Unit Linked Funds. Consequently, the solvency ratio dipped to 180.4% from 198.0% in the previous quarter, signaling tighter capital buffers despite the profit growth in the Shareholders' Account.

Capital raising initiative

To strengthen its balance sheet, the Board approved raising funds through subordinated debt instruments up to ₹28.75 billion. The issuance will be executed via private placement, subject to necessary approvals. This move complements the existing borrowings of ₹2.5 billion on the balance sheet as of September 30, 2026.

Business and distribution updates

The company’s distribution strategy remains anchored by its bancassurance partners. Canara Bank continues to drive urban reach with ~10,000 branches and ~80 million addressable customers, while HSBC Bank has expanded its footprint to 34 locations, focusing on premium and NRI segments. The agency channel crossed 1,900 sales force members, contributing ₹407 million APE in H1FY27.

Persistency ratios showed mixed trends. The 13-month persistency improved to 85.6% from 84.4% a year ago, while the 61-month persistency declined slightly to 54.6% from 55.5%. The product mix shifted towards traditional savings, which accounted for 59% of Total APE in H1FY27, up from 49.8% in H1FY26, reducing reliance on ULIPs.

Regulatory and audit updates

The financial results for the quarter and half-year ended September 30, 2026, were reviewed by joint statutory auditors M/s Brahmayya & Co. and M/s M Bhaskara Rao & Co., who issued a limited review report without observations. The auditors noted an emphasis of matter regarding the company's continued adoption of Indian GAAP instead of Ind AS, following a one-year forbearance granted by IRDAI.

The intimation regarding these results and the NCD issuance was filed under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the company disclosed that the audio recording of the analyst meet held on October 9, 2026, is available on its website. The notice was signed by Vatsala Sameer, Company Secretary and Compliance Officer.